Nomogram Predicting Survival in Gastroesophageal Variceal Bleeding Treated With Sclerotherapy and Cyanoacrylate
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Yingzhi Pang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Sclerotherapy, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Nomograms. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aims This study aimed to develop and validate a survival prediction model for patients with gastroesophageal variceal bleeding treated with combined sclerotherapy and cyanoacrylate injection.
Methods
Patient data were retrospectively collected and randomly divided into training and validation cohorts (7:3). Key prognostic variables in the training cohort were identified using random survival forest (RSF), least absolute shrinkage and selection operator (LASSO) regression, and extreme gradient boosting (XGBoost). A nomogram was developed with the Cox proportional hazards model. Kaplan–Meier (KM) curves assessed stratified survival, SHapley Additive exPlanations (SHAP) analysis interpreted variable contributions, and bootstrap resampling was used for internal validation. Model performance was evaluated by receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).
Results
The concordance index for 1‐ and 3‐year survival was 0.736 and 0.735 in the training cohort and 0.847 and 0.865 in the validation cohort. Time‐dependent ROC analysis showed AUCs of 0.736 (95% CI: 0.648–0.824) and 0.735 (95% CI: 0.657–0.813) in the training cohort and 0.869 (95% CI: 0.794–0.944) and 0.879 (95% CI: 0.812–0.945) in the validation cohort. Calibration curves demonstrated good agreement, and DCA confirmed substantial net clinical benefit across threshold probabilities ranging from 0.2 to 0.6.
Conclusions
The prognostic nomogram integrating age, MELD score, and the risk of rebleeding after combined endoscopic therapy demonstrated good clinical applicability and may provide a valuable reference for individualized treatment and follow‐up management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Internal Medicine, Northeast Yunnan Regional Central Hospital, Zhaotong, Yunnan, China.
ORCID-Profile: Wei Yan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pang, Y., Wang, H., Ding, L., Chen, Y., Ye, L., & Yan, W. (2026). Nomogram Predicting Survival in Gastroesophageal Variceal Bleeding Treated With Sclerotherapy and Cyanoacrylate. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70212
Vancouver
Pang Y, Wang H, Ding L, Chen Y, Ye L, Yan W. Nomogram Predicting Survival in Gastroesophageal Variceal Bleeding Treated With Sclerotherapy and Cyanoacrylate. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70212
BibTeX
@article{Pang2026,
author = {Pang, Yingzhi and Wang, Han and Ding, Linggui and Chen, Yao and Ye, Liangliang and Yan, Wei},
title = {Nomogram Predicting Survival in Gastroesophageal Variceal Bleeding Treated With Sclerotherapy and Cyanoacrylate},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70212}
}
EUVIMED